| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| MyoKardia (MYOK) | Credit Suisse/ Cowen and Company | $86.25 | n.a. | |||
| NB Capital Acquisition (NBCPU) (u) | Citigroup | 25.00 | $10.00 | $10.00 | $250.00 | n.a. |
| Advanced Accelerator Applications S.A. (AAAP) | Citigroup/ Jefferies | $75.00 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| AVINTIV (formerly PGI Specialty Materials) | BofA Merrill Lynch/ Citigroup | $100.00 | n.a. | |||
| New Terms | ||||||
| Albertsons Companies (ABS) | Goldman Sachs/ BofA Merrill Lynch/ Citigroup/ Morgan Stanley/Deutsche Bank Securities/ Credit Suisse/ Barclays | 65.31 | $23.00 | $26.00 | $1,600.00 | n.a. |
| Allegiance Bancshares (ABTX) | Baird/ Stephens | 2.60 | $22.00 | $24.00 | $59.80 | 2-Stars |
| CytomX Therapeutics (CTMX) | BofA Merrill Lynch/ Jefferies/ Cowen and Company | 6.67 | $14.00 | $16.00 | $100.00 | 1-Star |
| First Data (FDC) | Citigroup/ Morgan Stanley/ BofA Merrill Lynch/ KKR/ Barclays/ Credit Suisse/ Deutsche Bank Securities/ Goldman Sachs/ HSBC/ Mizuho Securities/ PNC Capital Markets/ SunTrust Robinson Humphrey/ Wells Fargo Securities | 160.00 | $18.00 | $20.00 | $3,040.00 | n.a. |
| Mauser Group N.V. (MSR) | BofA Merrill Lynch/ Citi/ Credit Suisse | $100.00 | n.a. | |||
| NovoCure (NVCR) | J.P. Morgan/ Deutsche Bank Securities/ Evercore ISI/ Wells Fargo Securities | 7.50 | $23.00 | $24.00 | $176.25 | 1-Star |
| PAVmed (PAVMU) (u) | Benchmark/ BANQ | 1.20 | $5.00 | $5.00 | $6.00 | N/C |
| SIRVA (SRVA) | Goldman Sachs | $175.00 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 28, 2015 | Manager(s) | Offered | Raised | Price | 10/2/15 | Change |
| Edge Therapeutics (EDGE) | Leerink Partners/ Credit Suisse | 7.32 | $80.47 | $11.00 | $17.48 | 58.91% |
| Performance Food Group (PFGC) | Credit Suisse/ Barclays/ Wells Fargo Securities/ Morgan Stanley | 14.50 | $275.50 | $19.00 | $21.18 | 11.47% |
| Mirna Therapeutics (MIRN) | Citigroup/ Leerink Partners | 6.25 | $43.75 | $7.00 | $7.04 | 0.57% |
| Surgery Partners (SGRY) | BofA Merrill Lynch/ Goldman Sachs/ Jefferies | 14.29 | $271.42 | $19.00 | $18.43 | -3.00% |
| NovoCure (NVCR) | J.P. Morgan/ Deutsche Bank Securities/ Evercore ISI/ Wells Fargo Securities | 7.50 | $165.00 | $22.00 | $18.28 | -16.91% |
